Screener
Madrigal Pharmaceuticals, Inc. MDGL Other Non-Current Assets
Other Non-Current Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 11,592 | 1,499 |
| Intangible assets, net | 7,187 | 7,381 |
| Operating lease right-of-use assets | 5,578 | 4,939 |
| Other noncurrent assets | 21,108 | — |
| Total assets | $1,244,645 | $1,259,589 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $34,514 | $48,878 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s other non-current assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported other non-current assets of $21.11M in Q2 2026.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude